| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A disease disregards anatomical planes: actinomycosis and an intrauterine device
|
Gilbert, Lucy
|
|
|
396 |
10264 |
p. 1766
|
article
|
| 2 |
Afghanistan braced for second wave of COVID-19
|
Cousins, Sophie
|
|
|
396 |
10264 |
p. 1716-1717
|
article
|
| 3 |
Applying for residency in the time of COVID-19
|
Fodje, Tema
|
|
|
396 |
10264 |
p. 1718
|
article
|
| 4 |
A tribute to some of the doctors who died from COVID-19
|
Green, Andrew
|
|
|
396 |
10264 |
p. 1720-1729
|
article
|
| 5 |
Department of Error
|
|
|
|
396 |
10264 |
p. 1736
|
article
|
| 6 |
Department of Error
|
|
|
|
396 |
10264 |
p. 1736
|
article
|
| 7 |
Direct oral anticoagulants: evidence and unresolved issues
|
Chan, Noel
|
|
|
396 |
10264 |
p. 1767-1776
|
article
|
| 8 |
Emergency use authorisation for COVID-19 vaccines: lessons from Ebola
|
Smith, Maxwell J
|
|
|
396 |
10264 |
p. 1707-1709
|
article
|
| 9 |
FAST: new look at the febuxostat safety profile
|
Bardin, Thomas
|
|
|
396 |
10264 |
p. 1704-1705
|
article
|
| 10 |
First human facial retransplantation: 30-month follow-up
|
Lantieri, Laurent
|
|
|
396 |
10264 |
p. 1758-1765
|
article
|
| 11 |
First-line treatment for type 2 diabetes: is it too early to abandon metformin?
|
Zaccardi, Francesco
|
|
|
396 |
10264 |
p. 1705-1707
|
article
|
| 12 |
Funding crisis threatens Palestinian refugee agency
|
Devi, Sharmila
|
|
|
396 |
10264 |
p. 1714
|
article
|
| 13 |
Harmful marketing to children
|
Powell, Darren
|
|
|
396 |
10264 |
p. 1734-1735
|
article
|
| 14 |
Harmful marketing to children – Authors' reply
|
Costello, Anthony
|
|
|
396 |
10264 |
p. 1735
|
article
|
| 15 |
Leveraging the COVID-19 response to end preventable child deaths from pneumonia
|
Fore, Henrietta H
|
|
|
396 |
10264 |
p. 1709-1711
|
article
|
| 16 |
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
|
Mackenzie, Isla S
|
|
|
396 |
10264 |
p. 1745-1757
|
article
|
| 17 |
Maintaining the HIV response in a world shaped by COVID-19
|
The Lancet,
|
|
|
396 |
10264 |
p. 1703
|
article
|
| 18 |
Maternal, neonatal, and child health is essential for meeting SDG 3.4
|
Modi, Neena
|
|
|
396 |
10264 |
p. 1731-1732
|
article
|
| 19 |
New international group on antimicrobial resistance
|
Zarocostas, John
|
|
|
396 |
10264 |
p. 1715
|
article
|
| 20 |
Offline: Europe and COVID-19—struggling with tragedy
|
Horton, Richard
|
|
|
396 |
10264 |
p. 1713
|
article
|
| 21 |
Osteoarthritis in 2020 and beyond: a Lancet Commission
|
Hunter, David J
|
|
|
396 |
10264 |
p. 1711-1712
|
article
|
| 22 |
Psychoanalysis in combatting mass non-adherence to medical advice
|
Ratner, Austin
|
|
|
396 |
10264 |
p. 1730
|
article
|
| 23 |
Ruxolitinib cream for the treatment of vitiligo
|
Uppal, Shelley K
|
|
|
396 |
10264 |
p. 1735-1736
|
article
|
| 24 |
Ruxolitinib cream for the treatment of vitiligo – Authors' reply
|
Rosmarin, David
|
|
|
396 |
10264 |
p. 1736
|
article
|
| 25 |
SARS-CoV-2 risk misclassification explains poor COVID-19 management
|
Hernández, Juan Martínez
|
|
|
396 |
10264 |
p. 1733-1734
|
article
|
| 26 |
Steven Laureys: a clinical focus on consciousness research
|
Lane, Richard
|
|
|
396 |
10264 |
p. 1719
|
article
|
| 27 |
Syndemic responses to COVID-19 should include an ecological dimension
|
Kenyon, Chris
|
|
|
396 |
10264 |
p. 1730-1731
|
article
|
| 28 |
The COVID-19 syndemic is not global: context matters
|
Mendenhall, Emily
|
|
|
396 |
10264 |
p. 1731
|
article
|
| 29 |
The Nobel Prize for discovery of HCV is a call to end hepatitis
|
Ward, John W
|
|
|
396 |
10264 |
p. 1733
|
article
|
| 30 |
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial
|
Silvain, Johanne
|
|
|
396 |
10264 |
p. 1737-1744
|
article
|
| 31 |
Who should be prioritised for COVID-19 vaccines?
|
Hassan-Smith, Zaki
|
|
|
396 |
10264 |
p. 1732-1733
|
article
|
Journal description